Lvl | Code | Display | Definition |
1 |
B01A |
ANTITHROMBOTIC AGENTS |
B01A - ANTITHROMBOTIC AGENTS |
2 |
B01AA03 |
warfarin |
B01AA03 - warfarin |
2 |
B01AB01 |
heparin |
B01AB01 - heparin |
2 |
B01AB04 |
dalteparin |
B01AB04 - dalteparin |
2 |
B01AB05 |
enoxaparin |
B01AB05 - enoxaparin |
2 |
B01AB10 |
tinzaparin |
B01AB10 - tinzaparin |
2 |
B01AC06 |
acetylsalicylic acid |
B01AC06 - acetylsalicylic acid |
2 |
B01AE07 |
dabigatran etexilate |
B01AE07 - dabigatran etexilate |
2 |
B01AF01 |
rivaroxaban |
B01AF01 - rivaroxaban |
2 |
B01AF02 |
apixaban |
B01AF02 - apixaban |
2 |
B01AX05 |
fondaparinux |
B01AX05 - fondaparinux |
1 |
B02AA02 |
tranexamic acid |
B02AA02 - Tranexamic acid |
1 |
B03XA01 |
erythropoietin |
B03XA01 - erythropoietin |
1 |
C10AA |
HMG CoA reductase inhibitors |
C10AA - HMG CoA reductase inhibitors |
1 |
H02 |
CORTICOSTEROIDS FOR SYSTEMIC USE |
H02 - CORTICOSTEROIDS FOR SYSTEMIC USE |
1 |
J01CF01 |
dicloxacillin |
J01CF01 - dicloxacillin |
1 |
J01CF02 |
cloxacillin |
J01CF02 - cloxacillin |
1 |
J01CF03 |
meticillin |
J01CF03 - meticillin |
1 |
J01CF05 |
flucloxacillin |
J01CF05 - flucloxacillin |
1 |
J01DB01 |
cefalexin |
J01DB01 - cefalexin |
1 |
J01DB03 |
cefalotin |
J01DB03 - cefalotin |
1 |
J01DC02 |
cefuroxime |
J01DC02 - cefuroxime |
1 |
J01FA01 |
erythromycin |
J01FA01 - erythromycin |
1 |
J01GB03 |
gentamicin |
J01GB03 - gentamicin |
1 |
J01XA01 |
vancomycin |
J01XA01 - vancomycin |
1 |
L01AA01 |
cyclophosphamide |
L01AA01 - cyclophosphamide |
1 |
L01AA02 |
chlorambucil |
L01AA02 - chlorambucil |
1 |
L01AA03 |
melphalan |
L01AA03 - melphalan |
1 |
L01AA06 |
ifosfamide |
L01AA06 - ifosfamide |
1 |
L01AA09 |
bendamustine |
L01AA09 - bendamustine |
1 |
L01AB01 |
busulfan |
L01AB01 - busulfan |
1 |
L01AC01 |
thiotepa |
L01AC01 thiotepa |
1 |
L01AD01 |
carmustine |
L01AD01 - carmustine |
1 |
L01AX03 |
temozolomide |
L01AX03 - temozolomide |
1 |
L01AX04 |
dacarbazine |
L01AX04 - dacarbazine |
1 |
L01BB05 |
fludarabine |
L01BB05 - fludarabine |
1 |
L01BC02 |
fluorouracil |
L01BC02 - Fluorouracil (5-FU) |
1 |
L01BC05 |
gemcitabine |
L01BC02 - Gemcitabine |
1 |
L01BC06 |
capecitabine |
L01BC06 - Capecitabine |
1 |
L01BC07 |
azacitidine |
L01BC07 - azacitidine |
1 |
L01CA02 |
vincristine |
L01CA02 - vincristine |
1 |
L01CA04 |
vinorelbine |
L01CA04 - Vinorelbine |
1 |
L01CB01 |
etoposide |
L01CB01 - etoposide |
1 |
L01CD01 |
paclitaxel |
L01CD01 - Paclitaxel |
1 |
L01CD02 |
docetaxel |
L01CD02 - Docetaxel |
1 |
L01CE02 |
irinotecan |
L01CE02 - Irinotecan |
1 |
L01DB01 |
doxorubicin |
L01DB01 - Doxorubicin |
1 |
L01DB03 |
epirubicin |
L01DB03 - Epirubicin |
1 |
L01DB07 |
mitoxantrone |
L01DB07 - mitoxantrone |
1 |
L01DB11 |
pixantrone |
L01DB11 - pixantrone |
1 |
L01DC01 |
bleomycin |
L01DC01 - bleomycin |
1 |
L01EA |
BCR-ABL tyrosine kinase inhibitors |
|
2 |
L01EA01 |
imatinib |
L01EA01 - imatinib |
2 |
L01EA02 |
dasatinib |
L01EA02 - dasatinib |
2 |
L01EA03 |
nilotinib |
L01EA03 - nilotinib |
2 |
L01EA04 |
bosutinib |
L01EA04 - bosutinib |
2 |
L01EA05 |
ponatinib |
L01EA05 - ponatinib |
2 |
L01EA06 |
Asciminib |
L01EA06 - Asciminib |
1 |
L01EB |
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors |
L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors |
1 |
L01EH |
Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors |
L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors |
1 |
L01EJ |
Janus-associated kinase (JAK) inhibitors |
Janus associerede kinase (JAK) hæmmere |
2 |
L01EJ01 |
ruxolitinib |
L01EJ01 - ruxolitinib |
1 |
L01EK |
Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors |
L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors |
1 |
L01EL01 |
ibrutinib |
L01EL01 - ibrutinib |
1 |
L01EL02 |
acalabrutinib |
L01EL02 - acalabrutinib |
1 |
L01EM01 |
idelalisib |
L01EM01 - idelalisib |
1 |
L01EN |
Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors |
L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors |
1 |
L01FA01 |
rituximab |
L01FA01 - rituximab |
1 |
L01FA02 |
ofatumumab |
L01FA02 - ofatumumab |
1 |
L01FA03 |
obinutuzumab |
L01FA03 - obinutuzumab |
1 |
L01FC01 |
daratumumab |
L01FC01 - daratumumab |
1 |
L01FC02 |
isatuximab |
L01FC02 - isatuximab |
1 |
L01FD01 |
trastuzumab |
L01FD01 - Trastuzumab |
1 |
L01FF |
PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
2 |
L01FF01 |
nivolumab |
L01FF01 - Nivolumab |
2 |
L01FF02 |
pembrolizumab |
L01FF02 - Pembrolizumab |
1 |
L01FG01 |
bevacizumab |
L01FG01 - Bevacizumab |
1 |
L01FX05 |
brentuximab vedotin |
L01FX05 - brentuximab vedotin |
1 |
L01FX08 |
elotuzumab |
L01FX08 - elotuzumab |
1 |
L01FX14 |
polatuzumab vedotin |
L01FX14 - polatuzumab vedotin |
1 |
L01XA01 |
cisplatin |
L01XA01 - Cisplatin |
1 |
L01XA02 |
carboplatin |
L01XA02 - Carboplatin |
1 |
L01XA03 |
oxaliplatin |
L01XA03 - Oxaliplatin |
1 |
L01XG01 |
bortezomib |
L01XG01 - bortezomib |
1 |
L01XG02 |
carfilzomib |
L01XG02 - carfilzomib |
1 |
L01XG03 |
ixazomib |
L01XG03 - ixazomib |
1 |
L01XH |
Histone deacetylase (HDAC) inhibitors |
L01XH - Histone deacetylase (HDAC) inhibitors |
2 |
L01XH01 |
vorinostat |
L01XH01 - vorinostat |
2 |
L01XH03 |
panobinostat |
L01XH03 - panobinostat |
1 |
L01XX05 |
hydroxycarbamide |
L01XX05 - hydroxycarbamide |
1 |
L01XX35 |
anagrelide |
L01XX35 - anagrelide |
1 |
L01XX52 |
venetoclax |
L01XX52 - venetoclax |
1 |
L03AB |
Interferons |
L03AB - Interferons |
1 |
L04A |
IMMUNOSUPPRESSANTS |
L04A - IMMUNOSUPPRESSANTS |
2 |
L04AA |
Selective immunosuppressants |
L04AA - Selective immunosuppressants |
3 |
L04AA34 |
alemtuzumab |
L04AA34 - alemtuzumab |
3 |
L04AA40 |
cladribine |
L04AA40 - cladribine |
1 |
L04AD01 |
ciclosporin |
L04AD01 - ciclosporin |
1 |
L04AX02 |
thalidomide |
L04AX02 - thalidomide |
1 |
L04AX04 |
lenalidomide |
L04AX04 - lenalidomide |
1 |
L04AX06 |
pomalidomide |
L04AX06 - pomalidomide |
1 |
M05BA03 |
pamidronic acid |
M05BA03 - pamidronic acid |
1 |
M05BA08 |
zoledronic acid |
M05BA08 - zoledronic acid |
1 |
M05BX04 |
denosumab |
M05BX04 - denosumab |
1 |
S01LA08 |
bevacizumab |
S01LA08 - Bevacizumab |
1 |
V10X |
OTHER THERAPEUTIC RADIOPHARMACEUTICALS |
V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS |
2 |
V10XA53 |
tositumomab/iodine (131I) tositumomab |
V10XA53 - tositumomab/iodine (131I) tositumomab |
2 |
V10XX02 |
ibritumomab tiuxetan (90Y) |
V10XX02 - ibritumomab tiuxetan (90Y) |